The SphenoCath® Solution

Medical science has attempted to “reset” chaotic signal impulse conduction in the Sphenopalatine Ganglion(SPG) for over 100 years. SPG/V2 neuralgia has been linked to painful conditions such as episodic and chronic migraine, trigeminal neuralgia, upper plate dental pain, and a typical facial neuropathies.

• This simple procedure is effective in providing immediate and long-term relief from SPG/PPG and V2 related conditions! (Central Dysautonomia).
• The SphenoCath® is an FDA-registered Class-1 transnasal drug delivery device.
• Careful tracking of procedural endeavors throughout the U.S. has shown exceptional patient tolerance and no reported severe adverse events or reactions.
• Practitioners across the U.S. have reported procedural efficacy of over 50% reduction in VAS [Visual Analog Scale] for greater than 80% of their patients.